Based on 30 years of clinical and research experience, backed by a careful assessment of four decades of published data, Dr. Faguet documented in The War on Cancer (Springer 2005), early advances in cancer treatment and patient survival that soon stalled. Ten years later and after an exhaustive analysis of evidence-based data available through 2013 that incorporates 755 references, he reveals the root causes of the stagnation in cancer control, including the role played by major stakeholders and advocates a coordinated national effort, akin to the Apollo program, to unveil the causes of cancer and their mastery. In the interim, Dr. Faguet urges caregivers to manage patients according to the four ethical principles of beneficence, non-maleficence, respect for patients' autonomy and justice especially at the end of life.
Dr. Faguet retired from the Medical College of Georgia (now Georgia Regents University) after a 30-year academic career that included clinical and bench research funded by the National Institutes of Health and the Department of Veterans Affairs, respectively. He was a member of numerous scientific societies, a consultant for the National Institutes of Health, the Department of Veterans Affairs, the National Science Foundation and the American Cancer Society and a reviewer for several prestigious scientific journals. He authored numerous peer-reviewed publications and seven book chapters and edited two books: Hematologic Malignancies (The Humana Press, 2000) & Chronic Lymphocytic Leukemia (The Humana Press, 2003). Since retiring, Dr. Faguet has authored three books on Public and Health Policy: The War on Cancer (Springer, 2005), Pain Control and Drug Policy (Praeger, 2010) and The Affordable Care Act (Algora, 2013). For more biographical data please visit: www.faguet.net
Preface. Part I An Historical overview of the war on cancer. The four-decade journey to the National Cancer Act of 1971. Part II Cancer through the ages.- An historical overview: From prehistory to WW11.- Our current knowledge.- Environmental carcinogens.- Part III Cancer statistics.- Assessing the enormity of the problem.- An uncontrolled problem.- Part IV How is advanced cancer treated?-The cancer-cell kill paradigm and beyond.- Complementary and alternative medicine.- The cell-kill paradigm: Bleak outcomes. Part V Stakeholders' role in the status quo.- The role of the National Cancer Institute.- Factors that impact Oncology research and practice.- The complex physician-patient interaction: Expectations vs. reality. Part VI A paradigm shift in cancer management.- Prevention & Early detection.- The holistic management of advanced cancer: A three-stage blueprint. Conclusions. References. Index.